NASDAQ: TGTXTg Therapeutics Revenue
Tg Therapeutics revenue was $616.29M for the trailing 12 months ending Dec 31, 2025, with 1,837.5% growth year over year. Quarterly revenue for the quarter (Q4 2025) ending on Dec 31, 2025 was $192.6M, up 19.1% from last quarter. For the last reported fiscal year 2025 ending Dec 31, 2025, TGTX annual revenue was $616.3M, with 87.3% growth year-over-year.
TGTX past revenue growth
How has TGTX's revenue growth performed historically?
Company
87.32%
Industry
394.14%
Market
87.23%
TGTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Industry Performance
TGTX's revenue has grown faster... subscribe to Premium to read more.
Revenue Growth vs Market Performance
TGTX's revenue growth is slowing... subscribe to Premium to read more.
Accelerating Revenue Growth Performance
TGTX revenue history
Current Revenue
$616.3M
Current Earnings
$447.2M
Current Profit Margin
72.6%
Be the first to know when TGTX announces revenue.
TGTX Revenue History By Year
| TGTX Yearly Revenue | TGTX Revenue | TGTX Change | TGTX Revenue Growth |
|---|---|---|---|
| 2025-12-31 | $616.29M | $287.28M | +87.32% |
| 2024-12-31 | $329.00M | $95.34M | +40.80% |
| 2023-12-31 | $233.66M | $230.88M | +8,290.02% |
| 2022-12-31 | $2.79M | -$3.90M | -58.36% |
| 2021-12-31 | $6.69M | $6.54M | +4,300.66% |
| 2020-12-31 | $152.00k | $0.00 | 0.00% |
| 2019-12-31 | $152.00k | $0.00 | 0.00% |
| 2018-12-31 | $152.00k | $0.00 | 0.00% |
| 2017-12-31 | $152.00k | $0.00 | 0.00% |
| 2016-12-31 | $152.00k | $0.00 | 0.00% |
| 2015-12-31 | $152.00k | $0.00 | 0.00% |
| 2014-12-31 | $152.00k | -$381.00 | -0.25% |
| 2013-12-31 | $152.38k | $133.33k | +699.98% |
| 2012-12-31 | $19.05k | N/A | N/A |
| 2011-12-31 | $0.00 | N/A | N/A |
| 2010-12-31 | $0.00 | N/A | N/A |
| 2009-12-31 | $0.00 | N/A | N/A |
| 2008-12-31 | $0.00 | N/A | N/A |
| 2007-12-31 | $0.00 | N/A | N/A |
| 2006-12-31 | $0.00 | N/A | N/A |
| 2005-12-31 | $0.00 | N/A | N/A |
| 2004-12-31 | $0.00 | N/A | N/A |
| 2003-12-31 | $0.00 | N/A | N/A |
| 2002-08-01 | $0.00 | -$2.71M | -100.00% |
| 2001-12-31 | $2.71M | -$2.65M | -49.39% |
| 2000-12-31 | $5.36M | $4.20M | +362.15% |
| 1999-12-31 | $1.16M | -$1.34M | -53.62% |
| 1998-12-31 | $2.50M | $2.50M | +109,165.73% |
| 1997-12-31 | $2.29k | -$95.36k | -97.66% |
| 1996-12-31 | $97.64k | N/A | N/A |
| 1995-12-31 | $0.00 | N/A | N/A |
| 1994-12-31 | N/A | N/A | N/A |
Tg Therapeutics Revenue FAQ
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletterWallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.